Lantern Pharma Inc. (LTRN)

Lantern Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8.1	21.94	37.2	51.52	19.23	1.23
Short-Term Investments	19.95	19.36	17.99	19.2	-	-
Cash & Short-Term Investments	28.05	41.3	55.2	70.73	19.23	1.23
Cash Growth	-37.56%	-25.17%	-21.96%	267.80%	1460.78%	176.76%
Other Receivables	-	0.86	0.59	0.18	-	-
Receivables	-	0.86	0.59	0.18	-	-
Prepaid Expenses	1.12	0.43	0.76	1.03	0.82	0
Restricted Cash	-	-	0.54	-	-	-
Other Current Assets	0.75	0.75	1.63	0.78	0.19	-
Total Current Assets	29.92	43.34	58.72	72.72	20.24	1.23
Property, Plant & Equipment	0.34	0.28	0.1	0.22	0.02	0.01
Long-Term Deferred Charges	-	-	-	-	0.1	0.19
Other Long-Term Assets	0.04	0.03	0.02	1.02	-	-
Total Assets	30.29	43.65	58.84	73.95	20.36	1.43
Accounts Payable	2.55	0.94	0.93	0.68	0.43	0.48
Accrued Expenses	-	-	-	-	-	0.01
Current Portion of Leases	0.2	0.17	0.05	0.15	-	-
Other Current Liabilities	0.86	1.56	1.81	1.49	0.12	0
Total Current Liabilities	3.6	2.68	2.8	2.33	0.55	0.49
Long-Term Debt	-	-	-	-	0.11	-
Long-Term Leases	0.09	0.06	-	0.05	-	-
Total Liabilities	3.7	2.74	2.8	2.38	0.66	0.49
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	96.77	96.26	95.69	96.69	32.36	7.69
Retained Earnings	-70.15	-55.24	-39.28	-25.02	-12.66	-6.75
Comprehensive Income & Other	-0.03	-0.11	-0.37	-0.09	-	-
Total Common Equity	26.6	40.91	56.04	71.57	19.7	0.94
Shareholders' Equity	26.6	40.91	56.04	71.57	19.7	0.94
Total Liabilities & Equity	30.29	43.65	58.84	73.95	20.36	1.43
Total Debt	0.29	0.23	0.05	0.2	0.11	-
Net Cash (Debt)	27.76	41.07	55.14	70.52	19.12	1.23
Net Cash Growth	-37.82%	-25.52%	-21.81%	268.82%	1451.97%	176.76%
Net Cash Per Share	2.58	3.79	5.08	6.47	4.44	0.62
Filing Date Shares Outstanding	10.78	10.74	10.86	10.78	11.17	2.57
Total Common Shares Outstanding	10.78	10.72	10.86	11.09	6.22	1.98
Working Capital	26.32	40.66	55.92	70.39	19.68	0.74
Book Value Per Share	2.47	3.82	5.16	6.45	3.17	0.48
Tangible Book Value	26.6	40.91	56.04	71.57	19.7	0.94
Tangible Book Value Per Share	2.47	3.82	5.16	6.45	3.17	0.48

Source: S&P Capital IQ. Standard template. Financial Sources.